RETRACTION article

Front. Pharmacol., 07 July 2023

Sec. Gastrointestinal and Hepatic Pharmacology

Volume 14 - 2023 | https://doi.org/10.3389/fphar.2023.1252194

Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells

Article metrics

View details

2,4k

Views

715

Downloads

Following publication, concerns were raised regarding the integrity of the images in the published figures. Image duplication concerns were identified in Figures 1A, 2C, 6B. The authors failed to provide a satisfactory explanation during the investigation, which was conducted in accordance with Frontiers’ policies. Given the concerns about the validity of the data, and the lack of raw data, the editors no longer have confidence in the findings presented in the article.

This retraction was approved by the Chief Editors of Frontiers in Pharmacology and the Chief Executive Editor of Frontiers. The authors agree to this retraction.

Summary

Keywords

Melatonin, Clock genes, liver fibrosis, Hepatic Stellate Cells, SR9009

Citation

Frontiers Editorial Office (2023) Retraction: Melatonin attenuates dysregulation of the circadian clock pathway in mice with CCl4-induced fibrosis and human hepatic stellate cells. Front. Pharmacol. 14:1252194. doi: 10.3389/fphar.2023.1252194

Received

03 July 2023

Accepted

03 July 2023

Published

07 July 2023

Approved by

Angelo A. Izzo, University of Naples Federico II, Italy

Volume

14 - 2023

Updates

Copyright

*Correspondence: Frontiers Editorial Office,

Disclaimer

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Cite article

Copy to clipboard


Export citation file


Share article

Article metrics